Open label aripiprazole in the treatment of youth with tic disorders

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 4, 2009, Pages 441-447

  Murphy, Tanya K ^a   Mutch, P Jane ^a   Reid, Jeannette M ^a   Edge, Paula J ^b   Storch, Eric A ^a   Bengtson, Michael ^b   Yang, Mark ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; ATOMOXETINE; CITALOPRAM; CLONAZEPAM; ESCITALOPRAM; METHYLPHENIDATE; MONTELUKAST; SERTRALINE; TRAZODONE; VALPROIC ACID; VENLAFAXINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSTHYMIA; ELECTROCARDIOGRAM; EXCITABILITY; FEMALE; HEADACHE; HUMAN; IRRITABILITY; JUVENILE; LIOTHYRONINE BLOOD LEVEL; MAJOR DEPRESSION; MALE; MOTOR PERFORMANCE; NAUSEA; OBSESSIVE COMPULSIVE DISORDER; OPEN STUDY; PARKINSON DISEASE; POLLAKISURIA; QT INTERVAL; RATING SCALE; RESTLESSNESS; SCHOOL CHILD; SIDE EFFECT; TIC; TREATMENT DURATION; WEIGHT GAIN;

ADOLESCENT; AGE FACTORS; CHILD; FEMALE; HUMANS; MALE; MOOD DISORDERS; PIPERAZINES; QUINOLONES; TIC DISORDERS; TREATMENT OUTCOME;

EID: 69549111415     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.0149     Document Type: Article

References (43)

1. th edition (DMS-IV). Washington (DC): American Psychiatric Association, 1994.
2. Bergin A, Waranch HR, Brown J, Carson K, Singer HS: Relaxation therapy in Tourette syndrome: A pilot study. Pediatric Neurol 18:136-142, 1998. (Pubitemid 28125411)
3. Blair J, Scahill L, StateM,MartinA: Electrocardiographic changes in children and adolescents treatedwith ziprasidone:Aprospective study. J Am Acad Child Adolesc Psychiatry 44:73-79, 2005. (Pubitemid 40019202)
4. Bowles TM, Levin GM: Aripiprazole: A new atypical antipsychotic drug. Ann Pharmacother 37:687-694, 2003.
5. Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA: Risperidone versus pimozide in Tourette's disorder: A comparative double-blind parallelgroup study. J ClinPsychiatry 62:50-56, 2001. (Pubitemid 32154319)
6. Bruun RD: Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder. Am J Psychiatry 145:621-624, 1988.
7. Budman CL, Gayer A, Lesser M, Shi Q, Bruun RD: An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychiatry 62:290-294, 2001. (Pubitemid 32428769)
8. Budman CL, Rockmore L, Stokes J, Sossin M: Clinical phenomenology of episodic rage in children with Tourette syndrome. J Psychosomat Res 55:59-65, 2003. (Pubitemid 36949570)
9. Chang HL, Tu MJ, Wang HS: Tourette's syndrome: Psychopathology in adolescents. Psychiatry Clin Neurosci 58:353-358, 2004.
10. Chrzanowski WK, Marcus RN, Torbeyns A, Nyilas M, McQuade RD: Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: A 52-week, open-label comparison with olanzapine. Psychopharmacology 189:259-266, 2006. (Pubitemid 44691547)
11. Conners CK: The Conners rating scales: Instruments for the Assessment of Childhood Psychopathology. Toronto: Multi-Health Systems, 1989.
12. Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JR: The use of aripiprazole in obsessive-compulsive disorder: Preliminary observations in 8 patients. J Clin Psychiatry 66:49-51, 2005.
13. Costa RM, Lin SC, Sotnikova TD, Cyr M, Gainetdinov RR, Caron MG, Nicolelis MA: Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron 52:359-369, 2006. (Pubitemid 44548339)
14. Davies L, Stern JS, Agrawal N, Robertson MM: A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole. Hum Psychopharmacol 21:447-453, 2006. (Pubitemid 44660184)
15. Deckersbach T, Rauch S, Buhlmann U, Wilhelm S: Habit reversal versus supportive psychotherapy in Tourette's disorder: A randomized controlled trial and predictors of treatment response. Behav Res Ther 44:1079-1090, 2006. (Pubitemid 43949248)
16. Dehning S, Riedel M, Muller N: Aripiprazole in a patient vulnerable to side effects. Am J Psychiatry 162:625, 2005. (Pubitemid 40343937)
17. Diniz J, Shavitt R, Pereira C, Hounie A, Pimentel I, Koran L, Dainesi S, Miguel E: Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. J Psychopharmacol [Epub ahead of print], 2009.
18. Duane DD: Aripiprazole in childhood and adolescence for Tourette syndrome. J Child Neurol 21:358, 2006. (Pubitemid 43891140)
19. Gao K, Muzina D, Gajwani P, Calabrese JR: Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J Clin Psychiatry 67:1327-1340, 2006. (Pubitemid 44583379)
20. Goetz CG: Clonidine and clonazepam in Tourette syndrome. Adv Neurol 58:245-251, 1992.
21. Guy W: Assessment Manual for Psychopharmacology, revised edition. Rockville (Maryland): National Institute of Mental Health, 1976.
22. Hernandez-Lopez S, Bargas J, Surmeier DJ, Reyes A, Galarraga E: D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance. J Neurosci 17:3334-3342, 1997. (Pubitemid 27175844)
23. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL):I reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997. (Pubitemid 27272932)
24. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ: The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566-573, 1989. (Pubitemid 19196295)
25. Matsushita M, Egashira N, Harada S, Okuno R, Mishima K, Iwasaki K, Nishimura R, Fujiwara M: Perospirone, a novel antipsychotic drug, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive-compulsive disorder. J Pharmacol Sci 99:154-159, 2005. (Pubitemid 41524453)
26. McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH: A comparison of weight change during treatment with olanzapine or aripiprazole: Results from a randomized, double-blind study. J Clin Psychiatry 65(Suppl 18):47-56, 2004.
27. Moss AJ: Measurement of the QT interval and the risk associated with QTc interval prolongation: A review. Am J Cardiol 72:23B-25B, 1993.
28. Murphy TK, Bengtson MA, Soto O, Edge PJ, Sajid MW, Shapira N, Yang M: Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol 8:489-490, 2005. (Pubitemid 41002504)
29. Poznanski EO, Cook SC, Carroll BJ: A depression rating scale for children. Pediatrics 64:442-450, 1979.
30. Robertson MM: Diagnosing Tourette syndrome. Is it a common disorder? J Psychosomat Res 55:3-6, 2003.
31. Robertson MM, Banerjee S, Eapen V, Fox-Hiley P: Obsessive compulsive behaviour and depressive symptoms in young people with Tourette syndrome. A controlled study. Eur Child Adolesc Psychiatry 11:261-265, 2002. (Pubitemid 36222416)
32. Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, Dittman VM, Chappell PB: Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study. J Am Acad Child Adolesc Psychiatry 39:292-299, 2000. (Pubitemid 30127607)
33. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF: Children's Yale-Brown Obsessive Compulsive Scale: Reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844-852, 1997. (Pubitemid 27250450)
34. Schneier FR, Martinez D, Abi-Dargham A, Zea-Ponce Y, Simpson HB, Liebowitz MR, Laruelle M: Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress Anxiety 25:1-7, 2008. (Pubitemid 351213919)
35. Silver AA, Shytle RD, Philipp MK, Wilkinson BJ, McConville B, Sanberg PR: Transdermal nicotine and haloperidol in Tourette's disorder: A double-blind placebo-controlled study. J Clin Psychiatry 62:707-714, 2001. (Pubitemid 32994934)
36. Storch EA, Lack CW, Simons LE, Goodman WK, Murphy TK, Geffken GR: A measure of functional impairment in youth with Tourette's syndrome. J Pediatr Psychol 32:950-959, 2007.
37. Storch EA, Lehmkuhl H, Geffken GR, Touchton A, Murphy TK: Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Depress Anxiety, 2008. (Pubitemid 351341964)
38. Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF: Tourette syndrome and tic disorders: A decade of progress. J Am Acad Child Adolesc Psychiatry 46:947-968, 2007b. (Pubitemid 47220680)
39. Szechtman H, Culver K, Eilam D: Role of dopamine systems in obsessive-compulsive disorder (OCD): Implications from a novel psychostimulant-induced animal model. Pol J Pharmacol 51:55-61, 1999. (Pubitemid 29145995)
40. Tranulis C, Potvin S, Gourgue M, Leblanc G, Mancini-Marie A, Stip E: The paradox of quetiapine in obsessive-compulsive disorder. CNS Spectr 10:356-361, 2005.
41. Uhr SB, Pruitt B, Berger PA, Stahl SM: Improvement of symptoms in Tourette syndrome by piquindone, a novel dopamine-2 receptor antagonist. Int Clin Psychopharmacol 1:216-220, 1986.
42. Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L: Habit reversal versus supportive psychotherapy for Tourette's disorder: A randomized controlled trial. Am J Psychiatry 160:1175-1177, 2003. (Pubitemid 41070980)
43. Yoo HK, Choi SH, Park S, Wang HR, Hong JP, Kim CY: An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders. J Clin Psychiatry 68:1088-1093, 2007. (Pubitemid 47340331)